VACCARO, OLGA
 Distribuzione geografica
Continente #
AS - Asia 4.454
NA - Nord America 3.725
EU - Europa 3.477
SA - Sud America 686
AF - Africa 126
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 12.478
Nazione #
US - Stati Uniti d'America 3.556
SG - Singapore 2.554
RU - Federazione Russa 1.771
CN - Cina 861
BR - Brasile 564
IT - Italia 505
HK - Hong Kong 420
VN - Vietnam 350
DE - Germania 225
FI - Finlandia 198
IE - Irlanda 179
UA - Ucraina 158
NL - Olanda 106
CA - Canada 99
GB - Regno Unito 99
IN - India 70
SE - Svezia 61
MX - Messico 51
AR - Argentina 47
FR - Francia 42
ZA - Sudafrica 39
CI - Costa d'Avorio 35
BD - Bangladesh 34
PL - Polonia 34
ES - Italia 29
AT - Austria 26
EC - Ecuador 24
KR - Corea 23
JP - Giappone 21
TR - Turchia 20
IQ - Iraq 16
LT - Lituania 15
ID - Indonesia 14
PY - Paraguay 13
IR - Iran 11
AE - Emirati Arabi Uniti 10
TN - Tunisia 10
UZ - Uzbekistan 10
MA - Marocco 9
VE - Venezuela 9
CO - Colombia 8
CL - Cile 7
UY - Uruguay 7
AL - Albania 5
EG - Egitto 5
PS - Palestinian Territory 5
PT - Portogallo 5
BE - Belgio 4
CR - Costa Rica 4
DZ - Algeria 4
GT - Guatemala 4
KE - Kenya 4
MY - Malesia 4
PE - Perù 4
PK - Pakistan 4
AZ - Azerbaigian 3
JM - Giamaica 3
AU - Australia 2
BO - Bolivia 2
BY - Bielorussia 2
CW - ???statistics.table.value.countryCode.CW??? 2
ET - Etiopia 2
GH - Ghana 2
HN - Honduras 2
KW - Kuwait 2
LB - Libano 2
NC - Nuova Caledonia 2
NG - Nigeria 2
NP - Nepal 2
NZ - Nuova Zelanda 2
SA - Arabia Saudita 2
TJ - Tagikistan 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CD - Congo 1
CG - Congo 1
CM - Camerun 1
CV - Capo Verde 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EU - Europa 1
GE - Georgia 1
GM - Gambi 1
GN - Guinea 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
JO - Giordania 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
Totale 12.458
Città #
Singapore 1.175
Moscow 449
Hong Kong 419
Chandler 403
Beijing 270
Ashburn 251
Santa Clara 197
Millbury 172
Hefei 149
Jacksonville 149
Princeton 134
Los Angeles 121
Naples 112
Ho Chi Minh City 108
Boston 92
Munich 91
Amsterdam 90
Buffalo 76
Nanjing 75
Dong Ket 72
Wilmington 72
São Paulo 69
New York 67
Napoli 61
Hanoi 56
Ottawa 53
Boardman 44
Redondo Beach 43
San Jose 40
The Dalles 40
Woodbridge 35
Ann Arbor 34
Chicago 32
Dallas 32
Des Moines 32
Turku 32
Houston 31
Rome 31
Nanchang 30
Seattle 28
Denver 27
Mexico City 27
Warsaw 26
Johannesburg 25
London 24
Norwalk 24
Montreal 23
Seoul 23
Brooklyn 22
Helsinki 22
Finale Ligure 21
Nuremberg 20
Orem 20
Stockholm 20
Lawrence 19
Rio de Janeiro 19
Tokyo 18
Atlanta 17
Tianjin 17
Belo Horizonte 16
Shenyang 16
Dublin 15
Jiaxing 15
Changsha 14
Chennai 14
Falkenstein 14
Biên Hòa 13
Brasília 13
Hebei 13
Lappeenranta 13
Milan 13
Poplar 13
Pune 13
Augusta 12
Falls Church 12
Frankfurt am Main 12
Ankara 11
Da Nang 11
Frattamaggiore 11
Hangzhou 11
Charlotte 10
Curitiba 10
Haiphong 10
Kronberg 10
Thái Nguyên 10
Casoria 9
Guayaquil 9
Kunming 9
Phoenix 9
Redwood City 9
Toronto 9
Fairfield 8
Orange 8
San Francisco 8
Tashkent 8
Düsseldorf 7
Manchester 7
Montevideo 7
Porto Alegre 7
Shanghai 7
Totale 6.327
Nome #
Spot-light on microbiota in obesity and cancer 179
Abitudini alimentari dei pazienti con diabete di tipo 2: Impatto delle tradizioni gastronomiche regionali. Uno studio di popolazione 171
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 157
Exposure to artificial light at night: A common link for obesity and cancer? 147
Dietary inflammatory index score, glucose control and cardiovascular risk factors profile in people with type 2 diabetes 142
Sex differences in food choices, adherence to dietary recommendations and plasma lipid profile in type 2 diabetes - The TOSCA.IT study 137
Performance of 2019 ESC risk classification and the Steno type 1 risk engine in predicting cardiovascular events in adults with type 1 diabetes: A retrospective study 130
Polyphenol intake and cardiovascular risk factors in a population with type 2 diabetes: The TOSCA.IT study 129
The combination of UCP3-55CT and PPARγ2Pro12Ala polymorphisms affects BMI and substrate oxidation in two diabetic populations 123
Dietary intake and major food sources of polyphenols in people with type 2 diabetes: The TOSCA.IT Study. 123
Beta2-adrenergic receptor and UCP3 variants modulate the relationship between age and type 2 diabetes mellitus 121
Uncoupling protein 2 G(-866)A polymorphism: a new gene polymorphism associated with C-reactive protein in type 2 diabetic patients. 119
Impact of a Mediterranean dietary pattern and its components on cardiovascular risk factors, glucose control, and body weight in people with type 2 diabetes: A real-life study 118
Pro12Ala polymorphism of the PPARgamma2 locus modulates the relationship between energy intake and body weight in type 2 diabetic patients 116
Association between Diet Quality and Index of Non-Alcoholic Steatohepatitis in a Large Population of People with Type 2 Diabetes: Data from the TOSCA.IT Study 115
Nutrient determinants of postprandial triglyceride response in a population-based sample of type II diabetic patients 115
A 19 year follow-up of a woman with lipoprotein lipase deficiency treated with biliopancreatic diversion 115
Influence of dietary fat and carbohydrates proportions on plasma lipids, glucose control and low-grade inflammation in patients with type 2 diabetes-The TOSCA.IT Study 114
White meat consumption, all-cause mortality, and cardiovascular events: A meta-analysis of prospective cohort studies 113
Post-prandial triglyceride profile in a population-based sample of Type 2 diabetic patients. 111
Relations between the Consumption of Fatty or Lean Fish and Risk of Cardiovascular Disease and All-Cause Mortality: A Systematic Review and Meta-Analysis 110
Plasma homocysteine and its determinants in diabetic retinopathy 110
Long term metabolic effects of two dietary methods of treating hyperlipidaemia 109
Renal duplex sonographic evaluation of type 2 diabetic patients 108
Pasta consumption and connected dietary habits: Associations with glucose control, adiposity measures, and cardiovascular risk factors in people with type 2 diabetes—TOSCA.IT study 107
PPARγ2 P12A polymorphism and albuminuria in patients with type 2 diabetes: A meta-analysis of case-control studies 106
Interaction between Pro12Ala polymorphism of PPARγ2 and diet on adiposity phenotypes. 106
Absence of association between Pro12Ala polymorphism of the PPARy2 gene and diabetes 106
Legume Consumption and Blood Pressure Control in Individuals with Type 2 Diabetes and Hypertension: Cross-Sectional Findings from the TOSCA.IT Study 105
The Double Pyramid: bridging nutrition and sustainability recommendations with traditional ways of eating 105
The PPARγ2 Pro12Ala variant is protective against progression of nephropathy in people with type 2 diabetes 104
Consumption of Dairy Foods and Cardiovascular Disease: A Systematic Review 103
Authors reply to: Limitations of the glycaemic index and the need for nuance when determining carbohydrate quality, by Mitch Kanter, Siddhartha Angadi, Julie Miller Jones, Katherine A. Beals 103
Plasma fibrinogen : a new factor of the metabolic syndrome. A population-based study 103
Plasma homocysteine and microvascular complications in type 1 diabetes. 102
Consumption of different animal-based foods and risk of type 2 diabetes: An umbrella review of meta-analyses of prospective studies 100
Fasting plasma free fatty acid concentrations and Pro12Ala polymorphism of the peroxisome proliferator-activated receptor (PPAR) 2 in healthy individuals. 100
Cardiovascular outcome trials of glucose-lowering strategies in type 2 diabetes 100
The Pro12Ala polymorphism of PPARγ2 modulates beta cell function and failure to oral glucose-lowering drugs in patients with type 2 diabetes 99
Pro12Ala polymorphism in the PPARG gene contributes to the development of diabetic nephropaty in chinese type 2 diabetic patients: comment on the dtudy by Liu et a1. 98
Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma2 is not associated with type 2 diabetes. 98
Iron deficiency and cardiovascular disease: an updated review of the evidence. 98
Uso del gel di piastrine autologo per la cura delle ulcere del piede diabetico 98
Relationship between smoking habits and the features of the metabolic syndrome in a non-diabetic population 97
Abdominal adiposity is associated with elevated C-reactive protein independent of BMI in healthy non obese people 97
Early abnormalities of the cardiac function in non-insulin dependent diabetes and impaired glucose tolerance. 97
Association between retinopathy and impaired peripheral arterial circulation in insulin dependent diabetic patients. 96
How Well Can We Control Dyslipidemias Through Lifestyle Modifications? 96
Comorbidity in an Older Population with Type-2 Diabetes Mellitus: Identification of the Characteristics and Healthcare Utilization of High-Cost Patients 96
Good for the heart, good for the Earth: proposal of a dietary pattern able to optimize cardiovascular disease prevention and mitigate climate change 95
Lipoprotein composition in individuals with impaired glucose tolerance. 95
Relation among lipoprotein subfractions and carotid atherosclerosis in Alaskan Eskimos (from the Gogadan Study) 94
The energy intake modulates the association of the 55CT polymorphism of UCP3 with body weight in type 2 diabetic patients 93
The Relationship between blood glucose and beat-to-beat variation in asymptomatic subjects. 92
Turning Wastes into Resources: Red Grape Pomace-Enriched Biscuits with Potential Health-Promoting Properties 91
Arterial hypertension increases left ventricular mass: role of tight blood pressure control. 91
Measurement of the intrarenal arterial resistence index for the identification and prediction of diabetic nephropathy. 91
Impaired glucose tolerance and risk factors for atherosclerosis. 90
Pathophysiological interrelations of obesity, impaired glucose tolerance, and arterial hypertension. 90
Lipoprotein particle distribution and size, insulin resistance and the metabolic sindrome in Alaska Eskimos, The GOCADAN Study. 89
Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: Impact on cardiovascular events. A randomized controlled trial 89
Association between low habitual physical activity and impaired glucose tolerance. 88
Recent trends in dietary habits of the italian population: Potential impact on health and the environment 87
Variants of uncoupling protein-2 gene and obesity: interaction with peroxisome proliferator-activated receptorgamma2. 86
COMPARATIVE EVALUATION OF SIMPLE INDICES OF INSULIN RESISTANCE. 86
Cardiovascular Effects of Pioglitazone or Sulfonylureas According to Pretreatment Risk: Moving Toward Personalized Care 86
Lipoprotein(a) concentrations in NIDDM and borderline hyperglycemia: a population-based study. 84
Under-treatment of migrants with diabetes in a universalistic health care system: the ARNO Observatory. 83
Clinical phenotype and beta-cell autoimmunity in Italian patients with adult-onset diabetes. 82
Fasting APO B48 levels are associated with microalbuminuria in patients with type 2 diabetes. 81
Cardiovascular response to exercise in subjects with reduced glucose tolerance. 81
Functional foods in the management of obesity and type 2 diabetes. 80
Dietary recommendations for prevention of atherosclerosis 79
Cerebrovascular reactivity by transcranial Doppler ultrasonography in insulin-dependent diabetic patients 77
The pathophysiology of lipid metabolism and diabetes. 77
Cardiac abnormalities in type 1 diabetes. 76
Hypertension, non insulin dependent diabetes, and intracellular sodium metabolism. 76
The “TOSCA.IT” trial: a study designed to evaluate the effect of pioglitazone vs sulphonylureas on CVD in type 2 diabetes 76
Different localization of early arterial lesions in insulin dependent diabetes mellitus and in familial hypercolesterolemia. 74
Hypertensive target organ damage predicts incident diabetes mellitus. 74
Relation of insulin resistance to left ventricular hypertension and diastolic dysfunction in obesity 73
RELATION OF INSULIN RESISTANCE TO LEFT VENTRICULAR HYPERTROPHY AND DIASTOLI DYSFUNCTION IN OBESITY. 73
Lipoprotein particle distribution and size, insulin resistance, and metabolic syndrome in Alaska Eskimos: the GOCADAN study. 73
Cardiovascular risk in women with diabetes 73
PPAR{gamma}2 P12A polymorphism and albuminuria in patients with type 2 diabetes: a meta-analysis of case-control studies. 73
Moderate hyperhomocysteinemia and retinopathy in insulin dependent diabetes 72
Indexation criteria of ventricular mass and predictive role of blood pressure and body composition. 71
Risk factors for peripheral atherosclerosis in non insulin dependent diabetes. 70
Diabetes mellitus and localization of obliterating arterial disease of the lower limbs. 69
Effect of nicardipine on insulin secretion, glucose and lipid metabolism in hypertensive, non-insulin dependent diabetics. 68
Effects of nicardipine on insulin secretion, glucose and lipid metabolism in hypertensive non-insulin dependent diabetics 68
Diagnosi precoce del Diabete: Glicemia, OGTT o HbA1c? 67
Impact of diabetes and coronary heart disease on mortality . 18.8 Years follow-up of primary screenees of the Multiple Risk Factors Intervention Trial (MRFIT). 66
Cardiovascular risk factors control according to diabetes status and prior cardiovascular events in patients managed in different settings 66
Is there any use for the OGTT? 65
Pro12Ala mutation in the peroxisome proliferator-activated receptor gamma2 (PPARgamma2) and severe obesity: a case-control study. 65
Patophysiological interrelations of obesity, impaired glucose tolerance, and arterial hypertension. 64
Impact of known and unknown diabetes on in-hospital mortality from ischemic stroke 63
Does impaired glucose tolerance predict hypertension ? A prospective analysis 63
Enhanced Na-Li conuntertransport – a marker of inherited susceptibility to Type 2 diabetes? 63
Totale 9.550
Categoria #
all - tutte 43.817
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.817


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021263 0 0 0 0 0 0 34 12 66 8 67 76
2021/2022936 41 11 4 15 17 17 28 36 176 58 167 366
2022/2023922 166 112 20 71 102 93 8 86 123 90 40 11
2023/2024639 19 117 100 29 29 44 7 59 11 3 137 84
2024/20254.040 178 275 5 38 100 222 379 241 376 447 1.406 373
2025/20264.748 843 546 758 802 1.426 315 58 0 0 0 0 0
Totale 12.696